Curaleaf obtains German and Canadian competition clearances for Aurora Cannabis acquisition
Curaleaf Holdings announced that competition‑law approvals have been secured in Germany and Canada for its proposed purchase of Aurora Cannabis. The German Federal Ministry for Economic Affairs and Energy approved the deal on October 20, 2026, and Canada’s Competition Bureau issued a no‑action letter on November 2, 2026, followed by confirmation from the German Federal Cartel Office on November 3, 2026. Curaleaf’s enhanced offer to buy all outstanding Aurora shares remains open until December 4, 2026, unless withdrawn or amended, and the company says the clearances increase certainty of closing the transaction.
Why it matters
The regulatory approvals remove the only competition‑law hurdles, improving the likelihood that Curaleaf’s bid will be completed (the company says). The cleared path may make Aurora shareholders more inclined to consider Curaleaf’s offer versus the competing Organigram proposal.
Key facts
- 1Germany’s Federal Ministry for Economic Affairs and Energy granted approval on October 20, 2026. prnewswire.com
- 2Canada’s Competition Bureau issued a no‑action letter on November 2, 2026. prnewswire.com
- 3Germany’s Federal Cartel Office confirmed on November 3, 2026 that the acquisition does not meet conditions for prohibition. prnewswire.com
- 4Curaleaf’s enhanced offer to purchase all outstanding Aurora common shares expires on December 4, 2026 unless withdrawn or amended. prnewswire.com
- 5Organigram’s competing bid values Aurora at approximately C$561 million on a fully diluted equity basis. securities.io
- 6Curaleaf’s offer was originally announced on October 6, 2026 and is described as a premium bid. securities.io
Summary written by AlphAI AI Desk from 6 of 6 sources. Not investment advice. Figures are as stated by the linked sources.